Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Teitelbaum

Showing results (11-20 of 12) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 12 results.
The Lancet. Psychiatry|January 30, 2023
Efficacy of oral versus long-acting antipsychotic treatment in patients with early-phase schizophrenia in Europe and Israel: a large-scale, open-label, randomised trial (EULAST)Inge Winter-van Rossum, Mark Weiser, Silvana Galderisi, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|June 3, 2019
New insights into tardive dyskinesia genetics: Implementation of whole-exome sequencing approachAnna Alkelai, Lior Greenbaum, Erin L Heinzen, et al.
Pageof 2

Showing results (11-20 of 12) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 12 results.
The Lancet. Psychiatry|January 30, 2023
Efficacy of oral versus long-acting antipsychotic treatment in patients with early-phase schizophrenia in Europe and Israel: a large-scale, open-label, randomised trial (EULAST)Inge Winter-van Rossum, Mark Weiser, Silvana Galderisi, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|June 3, 2019
New insights into tardive dyskinesia genetics: Implementation of whole-exome sequencing approachAnna Alkelai, Lior Greenbaum, Erin L Heinzen, et al.
Pageof 2